Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 3, 2000, Pages 825-830

  Bauman, G S ^a,c   Ino, Y ^a   Ueki, K ^a   Zlatescu, M C ^a   Fisher, B J ^a   Macdonald, D R ^a   Stitt, L ^b   Louis, D N ^a   Cairncross, J G ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

Chemotherapy; Chromosome 1p; Oligodendroglioma; Radiation

Indexed keywords

DNA;

ADULT; AGED; ALLELE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHROMOSOME 1P; FEMALE; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGE; OLIGODENDROGLIOMA;

EID: 0034307067     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00703-3     Document Type: Article

References (12)

1. Coons S.W., Johnson P.C., Scheithauer B.W., et al. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer. 79:1997;1381-1393.
2. Paleologos N.A., Cairncross J.G. Treatment of oligodendroglioma An update . Neurooncology. 1:1999;61-68.
3. Louis DN, Cavenee WK. Molecular biology of central nervous system tumors. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and practice of oncology. Philadelphia: Lippincott-Raven; 1997. p. 2013-2021.
4. Cairncross J.G., Ueki K., Zlatescu M.C., et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Canc Inst. 90:1998;1473-1479.
5. Donahue B., Scott C.B., Nelson J.S., et al. Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas A report of Radiation Therapy Oncology Group 83-02 . Int J Radiat Oncol Biol Phys. 38:1997;911-914.
6. Leighton C., Fisher B.J., Bauman G., et al. Supratentorial low-grade gliomas in adults An analysis of prognostic factors and timing of radiation . J Clin Oncol. 15:1997;1294-1301.
7. Cairncross J.G., Macdonald D.R. Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol. 23:(4):1988;360-364.
8. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumors of the central nervous system. Berlin: Springer-Verlag; 1993.
9. Reifenberger G, Kros JM, Burger PC; et al. Oligodendrogliomas and oligoastrocytomas. In: Kleihues P, Cavenee WK, editors. Histological typing of tumors of the nervous system. Lyon: WHO/IARC; 2000.
10. Louis D.N., von Deimling A., Seizinger B.R. A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am J Pathol. 141:1992;777-782.
11. Mason W., Louis D.N., Cairncross J.G. Chemosensitive gliomas in adults Which ones and why . J Clin Oncol. 15:1997;3423-3426.
12. Smith J.S., Perry A., Borell T.J., et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol. 18:(3):2000;636.